Drugs In The Making
  • Shruti's Blog
  • About Shruti Bhat
  • QUALITY BLOG
  • Industry News
  • Free Ebook
  • Research Updates
    • Drug Research
    • Clinical Research
  • Contact

Life Science Industry News

Pharmaceutical Industry Prepares For New Business Under Health Reform Law.

4/3/2010

0 Comments

 
Picture

Dr.Shruti Bhat, an Expert in Pharmaceutical industry, brings to you some highlights from current pharma business news-



Abbott Labs Completes Purchase Of Starlims.
  
"Abbott Laboratories said Monday it completed its purchase of Starlims Technology" for $123 million, or $14 per share. Abbott said that Starlims will "increase its position in the diagnostic testing market.

WHO: Drug-Resistant TB Killed 150,000 In 2008.  
The New York Times reported that the WHO announced data last week showing that "drug-resistant tuberculosis killed about 150,000 people in 2008, and half of all the world's cases are thought in be in China and India...

Transgene Sells Novartis Option On Rights To Experimental Cancer Vaccine.
Bloomberg News reported that French biotechnology company Transgene SA "sold Novartis AG an option on rights to the experimental TG4010 cancer vaccine in a deal that may fetch as much as $960 million...

Pharmaceutical Industry Prepares For New Business Under Health Reform Law.
The US drug industry fended off price curbs and other hefty restrictions in President Obama's healthcare law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage...

FDA clears Vytorin and Zetia of suspected link to cancer.
The Los Angeles Times blog reported "Booster Shots" that after examining two previous studies, a Food and Drug Administration review committee has determined that it is ...

Roche Seeks Acquisitions To Boost Its Research Programs.
Roche Holding AG Chief Executive Officer Severin Schwan said he seeks acquisitions that will bolster the company's research programs, rather than 'mega-mergers' designed to add immediate revenue...

Roche To Introduce At Least Six New Drugs By 2015.
In a separate story, Roche also expects to introduce "at least six new medicines by 2015." Roche "wants to expand" the use of its cancer drugs "by testing them in different tumors and earlier in the disease." The company "also is seeking to expand beyond cancer and tap markets for conditions such as diabetes and diseases of the central nervous system." 

Pharmaceutical Thefts Becoming More Common.
The $75 million heist at" Eli Lilly's "warehouse in Connecticut was just the most audacious example of a growing phenomenon: Thieves are stealing large quantities of prescription drugs for resale on the black market...
 

Full article at http://www.pharm-education.com/2010/04/who-drug-resistant-tb-killed-150000-in.html

Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

http://www.drshrutibhat.com
Expert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS .      

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    shruti bhat, pharmaceutical continuous improvement expert
    Dr. Shruti Bhat

    Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant


    Books

    shruti bhat kaizen expert

    Picture
    Picture

    Categories

    All


      Contact Form

    SEND
Disclaimer:

The website, blog information, audios, videos, white papers and all other associated published content on this website is the sole property of Innoworks, Canada and is under Copy Right protection. Not to be copied, distributed or used without prior authorization of the owner. The blog provides information for general knowledge sharing for community benefit and is for academic purpose only. Please give courtesy credits to respective authors in case information published here is used as a reference.
 
Additionally, information published on the blog, resource library etc. should not be considered or construed as legal and/or medical advice.  For diagnosis of an ailment, it is recommended that one seeks help of a registered medical practitioner, while medicines should be received from a registered pharmacist only. Seek advise of registered legal expert for any information pertaining law(s).

 The authors and website owner have used their best efforts in preparing this site. The information contained herein has been stated accurately to the best ability of the authors. The information contained herein is strictly for educational purposes. The author and website owner make no representation or warranties with respect to the accuracy, contrary interpretations of the subject matter herein, applicability, fitness or completeness of the contents. Therefore, if you wish to apply ideas contained on this website, you are taking full responsibility for your actions. The author and website owner specifically disclaim any liability that is incurred from the use or application of the contents sated here.

Please note that by continuing to read this site, you agree that you have read and understood this disclaimer and are continuing to read or utilize information from this site at your own responsibility and risk. Under no circumstances can you hold us responsible for any outcome or result from your having read or followed any of the expressions/suggestions/recommendations from this site.  We hope you expand your understanding and that many of the ideas and suggestions provided on this site help you. BUT we do not take on any implicit or explicit liability for anyone following any of those suggestions, ideas or advices. This is also applicable for any comments and discussions being carried out on this site.
 
For queries regarding any posted content, please feel free to contact the web administrator using contact form.
Terms & Conditions of site usage

©
2001- 2017 Copyrighted content, ALL RIGHTS RESERVED.


  • Shruti's Blog
  • About Shruti Bhat
  • QUALITY BLOG
  • Industry News
  • Free Ebook
  • Research Updates
    • Drug Research
    • Clinical Research
  • Contact